微血管减压术中假体材料的多中心调查:不良事件分析
日本微血管减压术学会向59家机构发放问卷,回顾2011年4月至2014年3月共2789例MVD手术。96.5%使用不可吸收材料,以PTFE为主(80.5%)。2672例首次手术中85例(3.2%)报告88起不良事件,再手术117例中13例见组织-假体粘连或肉芽肿形成。
要点
- 不可吸收材料占96.5%,PTFE最常用(80.5%)。
- 首次手术不良事件率3.2%,以中枢神经系统功能障碍为主。
- 再手术中粘连相关复发占全部再手术的11.1%。
核心结论
- 本调查中不良事件数量相当低,本文报告的任一假体材料行硬膜内使用可能合理,但仍期待开发更易操作且粘连更少的假体材料。
研究设计与样本
- 向日本微血管减压术学会全体会员发放问卷,获得59家机构的回答。
- 回顾2011年4月至2014年3月共2789例MVD手术,包括三叉神经痛1088例、面肌痉挛1670例及其他31例,其中再手术117例。
主要发现
- 不可吸收材料用于96.5%的MVD,包括PTFE(80.5%)、聚氨酯(11.9%)、ePTFE(2.1%)和丝线(1.47%)。
- 主要组合为PTFE联合纤维蛋白胶(58.7%),其次为单用PTFE(7.60%)。
- 2672例首次手术中85例(3.2%)报告88起不良事件,包括51起中枢神经系统功能障碍、15起伤口感染/裂开和10起其他事件。
- 117例再手术中13例报告组织-假体粘连和/或肉芽肿形成,粘连相关复发占全部再手术的11.1%。
关键数值与推荐
- 高、中、低手术量中心之间不良事件频率无显著差异(P = 0.077)。
临床怎么用
- 本文报告的假体材料在硬膜内使用可能合理,临床可依据本中心经验选择。
- 需关注再手术中组织-假体粘连和肉芽肿形成导致的复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the characteristics of materials used as prostheses for microvascular decompression surgery (MVDs) in Japan and their possible adverse events (AEs) to determine preferable materials for MVDs. METHODS: A questionnaire was sent to all members of the Japanese Society for MVDs, and answers were obtained from 59 institutions. RESULTS: Among a total of 2789 MVDs, 1088 operations for trigeminal neuralgia, 1670 for hemifacial spasm, and 31 others, including 117 reoperations, were performed between April 2011 and March 2014. Nonabsorbable material was used in 96.5% of MVDs, including polytetrafluoroethylene (PTFE) (80.5%), polyurethane (11.9%), expanded PTFE (2.1%), and silk thread (1.47%). The use of absorbable materials, including fibrin glue (87.5%), cellulose (13.5%), gelatin (4,77%), and collagen (1.76%), was reported. The major combinations were PTFE with fibrin glue (58.7%) followed by PTFE alone (7.60%). Eighty-eight AEs in 85 (3.2%) cases were reported among 2672 first operations. AEs included 51 central nervous system dysfunctions, 15 wound infections/dehiscence, and 10 others, which were presumed to be related to the intraoperative procedure. Among relatively high-, moderate-, and low-volume centers, there were no significant differences in the frequency of AEs (P = 0.077). Tissue-prosthesis adhesion and/or granuloma formation were reported in 13 cases of 117 reoperations. The incidence of adhesion-related recurrence was 11.1% of all reoperations. CONCLUSIONS: The number of AEs was quite low in this survey, and intradural use of any prosthesis reported in this paper might be justified; however, further development of easily handled and less-adhesive prosthesis materials is awaited.
引用
- Hasegawa M, Hatayama T, Kondo A, et al. Prosthesis Used in Microvascular Decompressions: A Multicenter Survey in Japan Focusing on Adverse Events. World Neurosurg. 2019. PMID: 31207376. doi:10.1016/j.wneu.2019.06.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。